Merger of Two Medical Device Makers
PLEASANTON, Calif - Thoratec Laboratories Corporation has announced that it will purchase Thermo Cardiosystmes, Inc. for $572 million in newly issued stock. Under the new deal, which is expected to close next year, Thoratec will exchange .835 a newly issued share for each share of Thermo Cardiosystems. Both companies are manufacturers of artificial heart devices. For more information visit www.thoratec.com.
Related Videos
Related Content
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Article
Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
